Transcatheter Arterial Chemoembolization for Liver Cancer: Is It Time to Distinguish Conventional from Drug-Eluting Chemoembolization?

[1]  W. Lau,et al.  A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  O. Matsui,et al.  Main Bile Duct Stricture Occurring After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma , 2010, CardioVascular and Interventional Radiology.

[3]  Thomas J Vogl,et al.  Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation. , 2009, European journal of radiology.

[4]  T. Vogl,et al.  Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study , 2009, CardioVascular and Interventional Radiology.

[5]  M. Roček,et al.  Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report , 2009, World journal of surgical oncology.

[6]  M. Choti,et al.  Single-Center Phase II Trial of Transarterial Chemoembolization With Drug-Eluting Beads for Patients With Unresectable Hepatocellular Carcinoma: Initial Experience in the United States , 2009, Cancer journal.

[7]  T. Vogl,et al.  Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols. , 2009, AJR. American journal of roentgenology.

[8]  K. Togashi,et al.  Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? , 2009, Radiology.

[9]  Jordi Rimola,et al.  Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma , 2009, Cancer.

[10]  K. Eichler,et al.  Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study. , 2009, Radiology.

[11]  K. Eichler,et al.  Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer , 2009, European Radiology.

[12]  P. Quaretti,et al.  Transarterial Chemoembolization for Hepatocellular Carcinoma with Drug-Eluting Microspheres: Preliminary Results from an Italian Multicentre Study , 2008, CardioVascular and Interventional Radiology.

[13]  J. Geschwind,et al.  Evaluation of different calibrated spherical polyvinyl alcohol microspheres in transcatheter arterial chemoembolization: VX2 tumor model in rabbit liver. , 2008, Journal of vascular and interventional radiology : JVIR.

[14]  T. de Baère,et al.  Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results. , 2008, Journal of vascular and interventional radiology : JVIR.

[15]  I. Kamel,et al.  Role of Functional Magnetic Resonance Imaging in Assessing Metastatic Leiomyosarcoma Response to Chemoembolization , 2008, Journal of computer assisted tomography.

[16]  W. Chapman,et al.  Chemoembolization of hepatocellular carcinoma: patient status at presentation and outcome over 15 years at a single center. , 2008, AJR. American journal of roentgenology.

[17]  D. Bluemke,et al.  Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. , 2008, AJR. American journal of roentgenology.

[18]  E. Alexopoulou,et al.  Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead , 2008, Abdominal Imaging.

[19]  A. Gouliamos,et al.  Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma with Drug Eluting Beads: Results of an Open-Label Study of 62 Patients , 2008, CardioVascular and Interventional Radiology.

[20]  J. Kettenbach,et al.  Drug-Loaded Microspheres for the Treatment of Liver Cancer: Review of Current Results , 2008, CardioVascular and Interventional Radiology.

[21]  A. Laurent.  Microspheres and nonspherical particles for embolization. , 2007, Techniques in vascular and interventional radiology.

[22]  K. Tai,et al.  A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[23]  I. Kamel,et al.  Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. , 2007, Journal of vascular and interventional radiology : JVIR.

[24]  A. Lloyd,et al.  Doxorubicin eluting beads − 1: Effects of drug loading on bead characteristics and drug distribution , 2007, Journal of materials science. Materials in medicine.

[25]  Eleni Liapi,et al.  Transcatheter and ablative therapeutic approaches for solid malignancies. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Bruix,et al.  Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. , 2007, Journal of hepatology.

[27]  K. Hong,et al.  Transcatheter arterial chemoembolization: current technique and future promise. , 2007, Techniques in vascular and interventional radiology.

[28]  H. Jaeger,et al.  Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma , 1996, CardioVascular and Interventional Radiology.

[29]  이광훈.  Drug-Eluting Particles for Interventional Pharmacology , 2007 .

[30]  A. Lewis,et al.  Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[31]  J. Bilbao,et al.  In Vivo Evaluation of a New Embolic Spherical Particle (HepaSphere) in a Kidney Animal Model , 2007, CardioVascular and Interventional Radiology.

[32]  A. Lewis,et al.  Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[33]  C. Georgiades,et al.  Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization. , 2006, Journal of vascular and interventional radiology : JVIR.

[34]  G. Benea,et al.  Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. , 2006, Anticancer research.

[35]  M. Makuuchi,et al.  Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. , 2006, Gastroenterology.

[36]  A. Lewis,et al.  Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. , 2006, Journal of vascular and interventional radiology : JVIR.

[37]  Shou-Dong Lee,et al.  The Sequential Changes of the Model for End-stage Liver Disease Score Correlate With the Severity of Liver Cirrhosis in Patients With Hepatocellular Carcinoma Undergoing Locoregional Therapy , 2006, Journal of clinical gastroenterology.

[38]  A. Lloyd,et al.  DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. , 2006, Journal of vascular and interventional radiology : JVIR.

[39]  G. Gandini,et al.  Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC) , 2006, European Radiology.

[40]  C. Georgiades,et al.  Effects of the type of embolization particles on carboplatin concentration in liver tumors after transcatheter arterial chemoembolization in a rabbit model of liver cancer. , 2005, Journal of vascular and interventional radiology : JVIR.

[41]  C. Georgiades,et al.  Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. , 2005, Journal of vascular and interventional radiology : JVIR.

[42]  K. Ahrar,et al.  Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors , 2005, Cancer.

[43]  M. Choti,et al.  Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. , 2005, Journal of vascular and interventional radiology : JVIR.

[44]  C. Georgiades,et al.  Case-controlled comparison of a percutaneous collagen arteriotomy closure device versus manual compression after liver chemoembolization. , 2005, Journal of vascular and interventional radiology : JVIR.

[45]  Dong Chen,et al.  Adjustment of lipiodol dose according to tumor blood supply during transcatheter arterial chemoembolization for large hepatocellular carcinoma by multidetector helical CT. , 2004, World journal of gastroenterology.

[46]  S. U. Lee,et al.  Cerebral lipiodol embolism during transcatheter arterial chemoembolization , 2004, Neurology.

[47]  M. Makuuchi,et al.  Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. , 2004, Archives of surgery.

[48]  M. Soulen,et al.  Chemoembolization of liver metastasis from breast carcinoma. , 2004, Journal of vascular and interventional radiology : JVIR.

[49]  T. Livraghi,et al.  Multimodal image‐guided tailored therapy of early and intermediate hepatocellular carcinoma: Long‐term survival in the experience of a single radiologic referral center , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[50]  K. Brown.  Fatal pulmonary complications after arterial embolization with 40-120- micro m tris-acryl gelatin microspheres. , 2004, Journal of vascular and interventional radiology : JVIR.

[51]  Hironobu Nakamura,et al.  Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma , 2004, Cancer Chemotherapy and Pharmacology.

[52]  M. Kusano,et al.  Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma — a comparison of L-TAE with Farmorubicin and L-TAE with Adriamycin (second cooperative study) , 2004, Cancer Chemotherapy and Pharmacology.

[53]  K. Stuart.  Chemoembolization in the management of liver tumors. , 2003, The oncologist.

[54]  R. Guillevin,et al.  In vitro study of the compatibility of tris-acryl gelatin microspheres with various chemotherapeutic agents. , 2003, Journal of vascular and interventional radiology : JVIR.

[55]  M. Yuen,et al.  Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: Results of a comparative study in 96 Chinese patients , 2003, American Journal of Gastroenterology.

[56]  M. Choti,et al.  Transcatheter Arterial Chemoembolization of Liver Tumors: Effects of Embolization Protocol on Injectable Volume of Chemotherapy and Subsequent Arterial Patency , 2003, CardioVascular and Interventional Radiology.

[57]  R. Virmani,et al.  Pathologic evaluation of a spherical polyvinyl alcohol embolic agent in a porcine renal model. , 2003, Journal of vascular and interventional radiology : JVIR.

[58]  J. Geschwind.  Chemoembolization for hepatocellular carcinoma: where does the truth lie? , 2002, Journal of vascular and interventional radiology : JVIR.

[59]  Pietro Andreone,et al.  Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. , 2002, Radiology.

[60]  Ramon Planas,et al.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.

[61]  John Wong,et al.  Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.

[62]  T. de Baère,et al.  Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors , 2002, European Radiology.

[63]  O. Matsui,et al.  Accumulation of Iodized Oil Within the Non-Neoplastic Liver Adjacent to Hepatocellular Carcinoma via the Drainage Routes of the Tumor After Transcatheter Arterial Embolization , 2001, CardioVascular and Interventional Radiology.

[64]  D. Leung,et al.  Determinants of postembolization syndrome after hepatic chemoembolization. , 2001, Journal of vascular and interventional radiology : JVIR.

[65]  R. Shlansky-Goldberg,et al.  Sarcomas metastatic to the liver: response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization. , 2001, Journal of vascular and interventional radiology : JVIR.

[66]  M. Makuuchi,et al.  Results of surgical and nonsurgical treatment for small‐sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan , 2000, Hepatology.

[67]  S. Wallace,et al.  Changes in rat liver microcirculation after experimental hepatic arterial embolization: comparison of different embolic agents. , 1999, Radiology.

[68]  J. Bruix,et al.  Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution , 1998, Hepatology.

[69]  A. Benson,et al.  Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature , 1998, Cancer.

[70]  M. A. Samphilipo,et al.  Histopathologic appearance of arterial occlusions with hydrogel and polyvinyl alcohol embolic material in domestic swine. , 1996, Journal of vascular and interventional radiology : JVIR.

[71]  B. Davidson,et al.  Human liver cancer cells and endothelial cells incorporate iodised oil. , 1996, British Journal of Cancer.

[72]  B. Choi,et al.  Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. , 1996, Radiology.

[73]  M. Winslet,et al.  Iodized oil in the treatment of hepatocellular carcinoma , 1994, The British journal of surgery.

[74]  G. Idéo,et al.  Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: A multivariate analysis of prognostic factors , 1994, Hepatology.

[75]  K. Amplatz,et al.  Therapeutic transcatheter arterial embolization. , 1974, Radiology.